Yuchun Lee - Jan 25, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Jan 25, 2023
Transactions value $
-$1,952,054
Form type
4
Date filed
1/27/2023, 03:18 PM
Previous filing
Jan 25, 2023
Next filing
Jan 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $289K +4K +213.33% $72.14 5.88K Jan 25, 2023 Direct
transaction VRTX Common Stock Sale -$250K -800 -13.62% $312.80 5.08K Jan 25, 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$823K -2.62K -51.65% $314.10 2.45K Jan 25, 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$182K -579 -23.59% $314.95 1.88K Jan 25, 2023 Direct F1, F2, F5
transaction VRTX Common Stock Options Exercise $289K +4K +213.33% $72.14 5.88K Jan 26, 2023 Direct
transaction VRTX Common Stock Sale -$95.3K -302 -5.14% $315.42 5.57K Jan 26, 2023 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$361K -1.14K -20.46% $316.82 4.43K Jan 26, 2023 Direct F1, F2, F7
transaction VRTX Common Stock Sale -$318K -1K -22.56% $317.95 3.43K Jan 26, 2023 Direct F1, F2, F8
transaction VRTX Common Stock Sale -$153K -478 -13.92% $319.25 2.96K Jan 26, 2023 Direct F1, F2, F9
transaction VRTX Common Stock Sale -$128K -400 -13.54% $320.25 2.56K Jan 26, 2023 Direct F1, F2, F10
transaction VRTX Common Stock Sale -$218K -680 -26.61% $320.94 1.88K Jan 26, 2023 Direct F1, F2, F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -4K -42.42% $0.00 5.43K Jan 25, 2023 Common Stock 4K $72.14 Direct F12
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -4K -73.68% $0.00 1.43K Jan 26, 2023 Common Stock 4K $72.14 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
F2 Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $312.80 (range $312.41 to $313.06).
F4 Open market sales reported on this line occurred at a weighted average price of $314.10 (range $313.53 to $314.50).
F5 Open market sales reported on this line occurred at a weighted average price of $314.95 (range $314.58 to $315.14).
F6 Open market sales reported on this line occurred at a weighted average price of $315.42 (range $315.23 to $315.66).
F7 Open market sales reported on this line occurred at a weighted average price of $316.82 (range $316.23 to $317.16).
F8 Open market sales reported on this line occurred at a weighted average price of $317.95 (range $317.43 to $318.35).
F9 Open market sales reported on this line occurred at a weighted average price of $319.25 (range $318.79 to $319.56).
F10 Open market sales reported on this line occurred at a weighted average price of $320.25 (range $319.80 to $320.77).
F11 Open market sales reported on this line occurred at a weighted average price of $320.94 (range $320.89 to $320.99).
F12 Fully vested.